Exit Text Mode

Macular Disease Foundation Australia logo

    Research news

    Research News

    MDFA awarded a total funding pool of more than $1 million in May 2021 to eight exciting researchers, bringing our total investment in research to $5.1m since 2011.

    Read more

    Most recent

    Faricimab one step closer

    Faricimab has taken one step closer towards clinics in Australia.

    Image of an Indian man in blue shirt

    Macular disease research highlights

    The latest research relevant to optometrists and other health professionals

    Optometrists needed for trial study

    Participate in new intervention designed to improve glaucoma and diabetic eye care.

    Update: Potential new treatments for nAMD and DMO

    The US FDA recently approved two treatments: Susvimo® and Vabysmo®.

    Research program: AMD and quality of life

    Volunteers with AMD sought to build a new computerised instrument.

    Reticular pseudodrusen in AMD: Update for optometrists

    Read the latest from CERA researchers Dr Zhichao Wu, Himeesh Kumar and Prof Robyn Guymer.

    Annual research update

    Macular Disease Research Update: November 2021

    MDFA’s summary of the past 12 months’ research into macular disease.

    Dr Sheela Kumaran

    Research study measuring the impact of AMD on quality of life

    If you have AMD, you could help this MDFA-funded study.

    Image of a young Asian man in glasses smiling at the camera

    2021 Research Update: Early-stage treatments

    Many potential drugs enter early-stage development. Only a few treatments will progress to late-stage development. This update details early stage treatments.